Press Releases

Bactisure White Paper – Role of Biofilm-Disrupting Technology in Management of Surgical Infection Risk: A Case Study of Bactisure Wound Lavage Solution

Read more

Annual Report 2019

Read more

Next Science Lists on Australian Securities Exchange

SYDNEY, Australia, 18 April 2019 – Following Next Science Limited’s successful $35 million initial public offer (IPO), the company’s shares are scheduled

Read more